Pending Medicare Fee-Schedule Selection For Gene Tests Has Significant Implications – Consultant
This article was originally published in The Pink Sheet Daily
Which payment system should incorporate new molecular diagnostic codes? CMS’ decision could have unsettling results for some gene test makers.
You may also be interested in...
How much physician “work” is required for the application of genetic tests will determine how CMS begins reimbursing for more than 100 assays in 2013.
Specific reimbursement codes have been developed for the first time for more than 100 genetic tests, but they will not be adopted by Medicare until at least 2013 as CMS figures out how to incorporate them into the payment system.
Startup Gelesis Inc. announced a $12 million funding round to support an FDA study for its Gelesis 100 “smart pill” as a tool to induce feelings of hunger and satiety.